Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignancies
出版年份 2011 全文链接
标题
Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignancies
作者
关键词
-
出版物
Future Oncology
Volume 7, Issue 7, Pages 827-839
出版商
Future Medicine Ltd
发表日期
2011-07-07
DOI
10.2217/fon.11.57
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ridaforolimus
- (2013) Drugs in research & development
- Targeted therapies in soft tissue sarcomas
- (2010) I. Judson ANNALS OF ONCOLOGY
- Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information
- (2010) E. J. O. Soini et al. ANNALS OF ONCOLOGY
- Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas
- (2010) Martee L Hensley CURRENT OPINION IN ONCOLOGY
- Phase IB Study of the mTOR Inhibitor Ridaforolimus With Capecitabine
- (2010) Antonella Perotti et al. JOURNAL OF CLINICAL ONCOLOGY
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel
- (2009) C. Sessa et al. ANNALS OF ONCOLOGY
- A Phase I Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Deforolimus in Patients with Advanced Malignancies
- (2009) C. M. Hartford et al. CLINICAL CANCER RESEARCH
- 1256 Phase I trial of oral Deforolimus in combination with Bevacizumab in patients with advanced solid tumours
- (2009) J. Nemunaitis et al. EJC SUPPLEMENTS
- Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
- (2009) Stefan Sleijfer et al. EUROPEAN JOURNAL OF CANCER
- Imatinib treatment for gastrointestinal stromal tumour (GIST)
- (2009) Lisandro F. Lopes et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Pharmacology of mTOR Inhibition
- (2009) D. A. Guertin et al. Science Signaling
- Fatal hepatic and renal toxicity as a complication of trabectedin therapy for radiation-induced sarcoma
- (2009) Amy M Pick et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
- (2008) D. A. Rizzieri et al. CLINICAL CANCER RESEARCH
- Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies
- (2008) Monica M. Mita et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search